Ticagrelor Removal by CytoSorb(®) in Patients Requiring Emergent or Urgent Cardiac Surgery: A UK-Based Cost-Utility Analysis

BACKGROUND: Acute coronary syndrome patients receiving dual antiplatelet therapy who need emergent or urgent cardiac surgery are at high risk of major bleeding, which can impair postoperative outcomes. CytoSorb(®), a blood purification technology based on adsorbent polymer, has been demonstrated to...

Descripción completa

Detalles Bibliográficos
Autores principales: Javanbakht, Mehdi, Trevor, Miranda, Rezaei Hemami, Mohsen, Rahimi, Kazem, Branagan-Harris, Michael, Degener, Fabian, Adam, Daniel, Preissing, Franziska, Scheier, Jörg, Cook, Suzanne F., Mortensen, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248150/
https://www.ncbi.nlm.nih.gov/pubmed/31620999
http://dx.doi.org/10.1007/s41669-019-00183-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248150/
https://www.ncbi.nlm.nih.gov/pubmed/31620999
http://dx.doi.org/10.1007/s41669-019-00183-w

Ejemplares similares